Teva Pharmaceutical Industries TEVA
NYSE TEVA
$41.28 -0.22 (-0.52%)
As of: Oct 19, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Operating Expenses (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Operating Expenses was $1.29 billion in Q2 2026, up 134.4% from $549 million a year earlier and up 144.7% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Operating Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Teva Pharmaceutical Industries' Operating Expenses was $3.02 billion through Jun 30, 2026, up 38.5% year-over-year; for FY2025, it was $2.3 billion, up 6.5% from FY2024.

  • Operating Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $2.16 billion in FY2024 (+2.1%), $2.12 billion in FY2023 (+4.8%), $2.02 billion in FY2022 (-2.3%) and $2.07 billion in FY2021 (-4.8%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q1 2009.
  • Compared with a year earlier, Operating Expenses was higher in six of the last eight quarters, with growth averaging 20.8%.
  • The best year-over-year quarter for Operating Expenses over five years was Q2 2026 (growth of 134.4%); the worst was Q4 2021 (a decline of 16.0%).
  • Per Business Quant data, TEVA's Operating Expenses in the three quarters before Q2 2026 was $526 million (Q1 2026), $634 million (Q4 2025) and $573 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 10.12 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 10.56 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 9.70 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 18.20 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 6.68 Bn
10 Teva Pharmaceutical Industries 48.14 Bn 34.98 Bn 2.15 Bn 1.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.29 Bn
Mar 31, 2026 526.00 Mn
Dec 31, 2025 634.00 Mn
Sep 30, 2025 573.00 Mn
Jun 30, 2025 549.00 Mn
Mar 31, 2025 544.00 Mn
Dec 31, 2024 549.00 Mn
Sep 30, 2024 538.00 Mn
Jun 30, 2024 552.00 Mn
Mar 31, 2024 520.00 Mn
Dec 31, 2023 519.00 Mn
Sep 30, 2023 521.00 Mn
Jun 30, 2023 547.00 Mn
Mar 31, 2023 530.00 Mn
Dec 31, 2022 498.00 Mn
Sep 30, 2022 458.00 Mn
Jun 30, 2022 541.00 Mn
Mar 31, 2022 521.00 Mn
Dec 31, 2021 521.00 Mn
Sep 30, 2021 513.00 Mn
API Access

Teva Pharmaceutical Industries Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TEVA&period=max&api_key=YOUR_API_KEY